Neuroimmunology of the Interleukins 13 and 4
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The cytokines interleukin 13 and 4 share a common heterodimeric receptor and are important modulators of peripheral allergic reactions. Produced primarily by T-helper type 2 lymphocytes, they are typically considered as anti-inflammatory cytokines because they can downregulate the synthesis of T-helper type 1 pro-inflammatory cytokines. Their presence and role in the brain is only beginning to be investigated and the data collected so far shows that these molecules can be produced by microglial cells and possibly by neurons. Attention has so far been given to the possible role of these molecules in neurodegeneration. Both neuroprotective or neurotoxic effects have been proposed based on evidence that interleukin 13 and 4 can reduce inflammation by promoting the M2 microglia phenotype and contributing to the death of microglia M1 phenotype, or by potentiating the effects of oxidative stress on neurons during neuro-inflammation. Remarkably, the heterodimeric subunit IL-13Rα1 of their common receptor was recently demonstrated in dopaminergic neurons of the ventral tegmental area and the substantia nigra pars compacta, suggesting the possibility that both cytokines may affect the activity of these neurons regulating reward, mood, and motor coordination. In mice and man, the gene encoding for IL-13Rα1 is expressed on the X chromosome within the PARK12 region of susceptibility to Parkinson’s disease (PD). This, together with finding that IL-13Rα1 contributes to loss of dopaminergic neurons during inflammation, indicates the possibility that these cytokines may contribute to the etiology or the progression of PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 1×
“Upon activation of IL-13Rα1, Stat1, 3, and 6 are phosphorylated and form a homodimer that migrates to the nucleus and binds to N6-GAS to drive transcription [31,42,44,45].”
BackgroundThe IL-4 receptor: signaling mechanisms and biologic functions
Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J., & Paul, W. E. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.701 · Cited by 1,545 · cited 5×
“IL-13 activates two intracellular signaling cascades: the JAK-STAT and the insulin receptor substrate (IRS)-phosphatidylinositol 31-kinase pathways [26,28,31].”
BackgroundInfluentialInterleukin‐13 in asthma pathogenesis
Wills‐Karp, M. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00215.x · Cited by 683 · cited 1×
“IL-13 and IL-4 also have the ability to downregulate the synthesis of T-helper type 1 (Th1) lymphocyte pro-inflammatory cytokines: for this reason they are normally listed as anti-inflammatory interleukins [8–10,15,18–20].”
BackgroundKim, E. Y., Battaile, J. T., Patel, A. C., You, Y., Agapov, E., Grayson, M. H., Benoit, L. A., Byers, D. E., Alevy, Y., Tucker, J., et al. (2008) · Nature Medicine · doi:10.1038/nm1770 · Cited by 523 · cited 3×
“The cytokines Interleukin 13 (IL-13) and interleukin-4 (IL-4) are two secreted proteins recognized for their role in promoting T-helper type 2 (Th2) lymphocyte-mediated allergic inflammation and atopy in the periphery [2–17].”
BackgroundComponents of a stat recognition code: Evidence for two layers of molecular selectivity
Schindler, U., Wu, P., Rothe, M., Brasseur, M., & McKnight, S. L. (1995) · Immunity · doi:10.1016/1074-7613(95)90013-6 · Cited by 246
Kawahara, K., Suenobu, M., Yoshida, A., Koga, K., Hyodo, A., Ohtsuka, H., Kuniyasu, A., Tamamaki, N., Sugimoto, Y., & Nakayama, H. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.01.049 · Cited by 113
Park, K. W., Baik, H. H., & Jin, B. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803392 · Cited by 84 · cited 2×
“On the other hand, other studies indicated that IL-13 and/or IL-4 could be neuroprotective either by directly reducing inflammation or by inducing the death of microglia cells that are considered to be cellular mediators of neuronal damage [47–50,59–65].”
BackgroundLee, H.-J., Park, H.-J., Starkweather, A., An, K., & Shim, I. (2016) · Mediators of Inflammation · doi:10.1155/2016/3501905 · Cited by 30 · cited 1×
“Neuronal production of IL-4 has been described lately in the noradrenergic neurons of the locus coeruleus, in which its release appears to be sensitive to behavioral stress [56].”
Background
Cited by
The Translational Potential of Microglia and Monocyte-Derived Macrophages in Ischemic Stroke
Wicks, E. E., Ran, K. R., Kim, J. E., Xu, R., Lee, R. P., & Jackson, C. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.897022 · Cited by 92
Ott, B. R., Jones, R. N., Daiello, L. A., de la Monte, S. M., Stopa, E. G., Johanson, C. E., Denby, C., & Grammas, P. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00245 · Cited by 91
Mao, R., Zhang, C., Chen, J., Zhao, G., Zhou, R., Wang, F., Xu, J., Yang, T., Su, Y., Huang, J., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.115 · Cited by 68
Interleukin-4 Is a Participant in the Regulation of Depressive-like Behavior
Wachholz, S., Knorr, A., Mengert, L., Plümper, J., Sommer, R., Juckel, G., & Friebe, A. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.03.020 · Cited by 45
Lee, H.-J., Park, H.-J., Starkweather, A., An, K., & Shim, I. (2016) · Mediators of Inflammation · doi:10.1155/2016/3501905 · Cited by 30
Metadata
- Authors
- Mori, S., Maher, P., & Conti, B.
- Venue
- Brain Sciences
- Publisher
- MDPI AG
- Published
- 2016-06-13
- Volume
- 6
- Issue
- 2
- Pages
- 18
- ISSN
- 2076-3425 (ISSN-L)
- OpenAlex
- W2410533323
- Cited by
- 127
- References
- 8
- FWCI
- 4.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroimmunology of the Interleukins 13 and 4. https://app.cochat.ai/papers/10.3390/brainsci6020018
- The paper
- Mori, S., Maher, P., & Conti, B. (2016). Neuroimmunology of the Interleukins 13 and 4. Brain Sciences. https://doi.org/10.3390/brainsci6020018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.